SVP of Life Sciences and R&D Solutions
It’s no secret that bringing new drugs to market is a massively expensive and risky undertaking. In 2016, roughly $60 billion was spent on clinical trials, yet only 22 drugs actually received FDA approval. One of the primary reasons for the extreme costs relates to the difficulty in recruiting a sufficient number of patients to complete clinical trials in a timely manner. Consider the fact that 90% of clinical trials fail to complete enrollment within the period of time anticipatedwith an average delay in completion of 6 weeks, and nearly 50% of all trial sites fail to ever reach established enrollment goals.
When poor recruitment delays a trial’s completion, new drugs remain on manufacturers’ shelves, instead of being made available to those who need them the most. This problem has proved intractable and tremendously costly over time.The company I joined recently, however, has a solution that I’m excited to announce.
Outcome Health (formerly known as ContextMedia:Health) is a digital health decision platform that delivers to patients actionable intelligence on medical conditions, treatments, and lifestyle changes that improve quality of life. The actionable intelligence is delivered through TVs, digital anatomy wallboards, and tabletscurrently located in the waiting rooms, exam rooms, and infusion suites of 55,000 outpatient facilities throughout the U.S., a number that continues to grow by more than 1,500 each month. Areas of practice at those facilities presently include cardiology, dermatology, endocrinology, gastroenterology, general health, infectious disease, neurology, OB/GYN, oncology, ophthalmology, optometry, pediatrics, psychiatry, and urology.
Given Outcome Health’s presence in so many medical facilities throughout the country, life sciences companies can use our digital platform to reach patients in a highly-targeted way and at the point-of-care, where meaningful information about active clinical trials can be made available at the moment it is most impactful – a capability previously unavailable in clinical trial recruitment.
To help us develop content that meets the needs of potential trial volunteers, I’m proud to say we have partnered with The Center for Information and Study on Clinical Research Participation (CISCRP), a nonprofit dedicated to informing the public, patients, medical/research communities, and policy makers about clinical research, to produce educational content for use at clinical trial point-of-care campaigns.
I firmly believe that this new solution will end the bottleneck in clinical trial recruitment, once and for all. And the industry is already taking notice. According to Jen Reichuber, founder of Altani Associates, a clinical-trial consulting firm, “Outcome Health has applied their time-tested platform to a key industry challenge. The platform brings an important new cost-effective channel to reach patients at scale.”
Interested to learn more? I’d love to hear from you! Come see me at the SCOPE conference in Miami. From January 24-26, 2017, I’ll be demonstrating Outcome Health’s new clinical trial recruitment platform at Booth No. 213. And if you can’t make it to SCOPE, be sure to reach out to me directly: firstname.lastname@example.org